Mohib Uddin
- Serum amyloid A augments mucosal immunity by opposing resolving lipoxinA4 signaling in chronic lung diseaseBy Steven Bozinovski, Mohib Uddin, Ross Vlahos, Michelle Thompson, Anne-Sophie Merritt, Peter Wark, Anastasia Hutchinson, Louis Irving, Bruce Levy and Gary AndersonSteven Bozinovski1Pharmacology, University of Melbourne, Parkville, Victoria, AustraliaMohib Uddin3Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, United StatesRoss Vlahos1Pharmacology, University of Melbourne, Parkville, Victoria, AustraliaMichelle Thompson2Respiratory Medicine, Royal Melbourne Hospital, Parkville, Victoria, AustraliaAnne-Sophie Merritt1Pharmacology, University of Melbourne, Parkville, Victoria, AustraliaPeter Wark4Respiratory and Sleep Medicine, University of Newcastle, Newcastle, AustraliaAnastasia Hutchinson2Respiratory Medicine, Royal Melbourne Hospital, Parkville, Victoria, AustraliaLouis Irving2Respiratory Medicine, Royal Melbourne Hospital, Parkville, Victoria, AustraliaBruce Levy3Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, United StatesGary Anderson1Pharmacology, University of Melbourne, Parkville, Victoria, Australia
- PI3Kδ inhibition confer efficacy in experimental models of allergic airway inflammationBy Sandra Rodrigo Blomqvist, Rikard Pehrson, Karin Björhall, Susanne Arlbrandt, Britta Bonn, Matthew Perry, Mohib Uddin, Neil Holden, Matt Thomas and Kostantinos KarabelasSandra Rodrigo BlomqvistRespiratory, Inflammation and Autoimmunity iMED, AstraZeneca, Mölndal, SwedenRikard PehrsonRespiratory, Inflammation and Autoimmunity iMED, AstraZeneca, Mölndal, SwedenKarin BjörhallRespiratory, Inflammation and Autoimmunity iMED, AstraZeneca, Mölndal, SwedenSusanne ArlbrandtRespiratory, Inflammation and Autoimmunity iMED, AstraZeneca, Mölndal, SwedenBritta BonnRespiratory, Inflammation and Autoimmunity iMED, AstraZeneca, Mölndal, SwedenMatthew PerryRespiratory, Inflammation and Autoimmunity iMED, AstraZeneca, Mölndal, SwedenMohib UddinRespiratory, Inflammation and Autoimmunity iMED, AstraZeneca, Mölndal, SwedenNeil HoldenRespiratory, Inflammation and Autoimmunity iMED, AstraZeneca, Mölndal, SwedenMatt ThomasRespiratory, Inflammation and Autoimmunity iMED, AstraZeneca, Mölndal, SwedenKostantinos KarabelasRespiratory, Inflammation and Autoimmunity iMED, AstraZeneca, Mölndal, Sweden
- Enhanced neutrophil extracellular trap (NET) formation in sputum of stable COPD patientsBy Frauke Pedersen, Sebastian Marwitz, Torsten Goldmann, Anne Kirsten, Helgo Magnussen, Klaus F. Rabe, Mohib Uddin and Henrik WatzFrauke Pedersen1Respiratory Medicine, LungClinic Grosshansdorf, Grosshansdorf, Germany4Pulmonary Research Institute, LungClinic Grosshansdorf, Grosshansdorf, GermanySebastian Marwitz2Clinical and Experimental Pathology, Research Center, Borstel, GermanyTorsten Goldmann2Clinical and Experimental Pathology, Research Center, Borstel, GermanyAnne Kirsten4Pulmonary Research Institute, LungClinic Grosshansdorf, Grosshansdorf, GermanyHelgo Magnussen4Pulmonary Research Institute, LungClinic Grosshansdorf, Grosshansdorf, GermanyKlaus F. Rabe1Respiratory Medicine, LungClinic Grosshansdorf, Grosshansdorf, GermanyMohib Uddin3Translational Science, Astra Zeneca, Mölndal, SwedenHenrik Watz4Pulmonary Research Institute, LungClinic Grosshansdorf, Grosshansdorf, Germany
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.